Insulet PODD
NASDAQ PODD
$130.47 -2.37 (-1.78%)
At close: Sep 30, 2026 · 4:00 PM EDT

Insulet (PODD) Income from Continuing Operations (2010 - 2026)

Updated

Insulet (PODD) reported Income from Continuing Operations of $95 million for Q2 2026, up 322.2% from $22.5 million a year earlier and up 4.3% from the prior quarter.

Analysis

Insulet (PODD) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Insulet's Income from Continuing Operations came in at $375.4 million, up 58.9% year-over-year; for FY2025, it came in at $247.1 million, down 40.9% from FY2024.

  • Income from Continuing Operations has a five-year compound annual growth rate of 105.2% (FY2020 to FY2025).
  • By year, Income from Continuing Operations came in at $418.3 million in FY2024 (+102.7%), $206.4 million in FY2023, $4.6 million in FY2022 (-72.6%) and $16.8 million in FY2021 (+147.1%).
  • Five-year quarterly Income from Continuing Operations spans a low of -$35 million in Q2 2022 and a high of $188.6 million in Q2 2024.
  • Year over year, Income from Continuing Operations has now increased in each of the last four quarters, with growth averaging 52.6% over the last eight quarters.
  • The high point for year-over-year Income from Continuing Operations in five years was Q2 2024 (growth of 590.8%); the low point was Q2 2025 (a decline of 88.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $91.1 million (Q1 2026), $101.7 million (Q4 2025) and $87.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 1.76 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 928.00 Mn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 823.20 Mn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 1.48 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn -220.00 Mn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 905.00 Mn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 241.40 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 451.00 Mn
10 Insulet 9.21 Bn 6.72 Bn 562.60 Mn 95.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.00 Mn
Mar 31, 2026 91.10 Mn
Dec 31, 2025 101.70 Mn
Sep 30, 2025 87.60 Mn
Jun 30, 2025 22.50 Mn
Mar 31, 2025 35.50 Mn
Dec 31, 2024 100.70 Mn
Sep 30, 2024 77.50 Mn
Jun 30, 2024 188.60 Mn
Mar 31, 2024 51.50 Mn
Dec 31, 2023 103.40 Mn
Sep 30, 2023 51.90 Mn
Jun 30, 2023 27.30 Mn
Mar 31, 2023 23.80 Mn
Dec 31, 2022 17.00 Mn
Sep 30, 2022 -5.20 Mn
Jun 30, 2022 -35.00 Mn
Mar 31, 2022 27.80 Mn
Dec 31, 2021 29.20 Mn
Sep 30, 2021 12.60 Mn
API Access

Insulet Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PODD&period=max&api_key=YOUR_API_KEY